# Effect of Tadalafil on Cerebral Large Arteries in Stroke

> **NCT02801032** · PHASE2 · COMPLETED · sponsor: **Christina Kruuse** · enrollment: 20 (actual)

## Conditions studied

- Stroke, Lacunar
- Cerebral Small Vessel Diseases

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02801032
- **Lead sponsor:** Christina Kruuse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-29
- **Primary completion:** 2017-08-04
- **Final completion:** 2017-08-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801032, "Effect of Tadalafil on Cerebral Large Arteries in Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02801032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*